In vitro/in vivo biorecognition of lectin-immobilized fluorescent nanospheres for human colorectal cancer cells

Journal of Controlled Release

Volumn 134, Issue 1, 2009, Pages 2-10

  Sakuma, Shinji ^a   Yano, Takanori ^a   Masaoka, Yoshie ^a   Kataoka, Makoto ^a   Ken ichiro Hiwatari, ^b   Tachikawa, Hiroyuki ^b   Shoji, Yoshikazu ^b   Kimura, Ryoji ^b   Ma, Huaiyu ^c   Yang, Zhijian ^c   Tang, Li ^c   Hoffman, Robert M ^c,d   Yamashita, Shinji ^a  

^a SETSUNAN UNIVERSITY   (Japan)

^b ADEKA CORPORATION   (Japan)

^c ANTICANCER INC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Colonoscopy; Colorectal cancer; Endoscopic imaging agent; Lectin; Orthotopic cancer model

Indexed keywords

COLONOSCOPY; COLORECTAL CANCER; ENDOSCOPIC IMAGING AGENT; LECTIN; ORTHOTOPIC CANCER MODEL;

ANIMAL CELL CULTURE; CARBOHYDRATES; CELLS; ENDOSCOPY; FLUORESCENCE; NANOSPHERES; POLYSTYRENES; SUGAR (SUCROSE); SUGARS; TUMORS;

AGENTS;

ACETAMIDE; ANTIGEN; BETA DEXTRO GALACTOSYL(1,3) N ACETYLGALACTOSAMINE; CONTRAST MEDIUM; COUMARIN; COUMARIN 6; GALACTOSAMINE; LECTIN IMMOBILIZED FLUORESCENT NANOSPHERE; NANOSPHERE; PEANUT AGGLUTININ; POLY(N VINYLACETAMIDE); THOMSEN FRIEDENREICH ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ENCAPSULATION; FEMALE; FLUORESCENCE; HUMAN; HUMAN CELL; IMMOBILIZED CELL; IN VITRO STUDY; IN VIVO STUDY; INTESTINE EPITHELIUM CELL; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ACETAMIDES; ANIMALS; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CELL LINE; COLORECTAL NEOPLASMS; COUMARINS; DIAGNOSTIC IMAGING; FLUORESCENT DYES; HUMANS; MICE; MICE, NUDE; MODELS, ANIMAL; NANOSPHERES; PEANUT AGGLUTININ; POLYVINYLS; THIAZOLES;

EID: 59049108198     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2008.10.017     Document Type: Article

References (49)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., and Thun M.J. Cancer statistics. CA Cancer J. Clin. 56 2 (2006) 106-130
2. http://www.cancer.gov.
3. Balch G.C., De Meo A., and Guillem J.G. Modern management of rectal cancer: a 2006 update. World J. Gastroenterol. 12 20 (2006) 3186-3195
4. Muto T., and Oya M. Recent advances in diagnosis and treatment of colorectal T1 carcinoma. Dis. Colon Rectum 46 10 Suppl. (2003) S89-S93
5. Harford W.V. Colorectal cancer screening and surveillance. Surg. Oncol. Clin. N. Am. 15 1 (2006) 1-20
6. Lieberman D. Screening for colorectal cancer in average-risk populations. Am. J. Med. 119 9 (2006) 728-735
7. Ponchon T. Endoscopic mucosal resection. J. Clin. Gastroenterol. 32 1 (2001) 6-10
8. Kudo S., Tamegai Y., Yamano H., Imai Y., Kogure E., and Kashida H. Endoscopic mucosal resection of the colon: the Japanese technique. Gastrointest. Endosc. Clin. N. Am. 11 3 (2001) 519-535
9. Rembacken B., Fujii T., and Kondo H. The recognition and endoscopic treatment of early gastric and colonic cancer. Best Prac. Res. Clin. Gastroenterol. 15 2 (2001) 317-336
10. Kashida H., and Kudo S. Early colorectal cancer: concept, diagnosis, and management. Int. J. Clin. Onco. 11 1 (2006) 1-8
11. Tischendorf J.J., Wasmuth H.E., Koch A., Hecker H., Trautwein C., and Winograd R. Value of magnifying chromoendoscopy and narrow band imaging (NBI) in classifying colorectal polyps: a prospective controlled study. Endoscopy 39 12 (2007) 1092-1096
12. DaCosta R.S., Wilson B.C., and Marcon N.E. Fluorescence and spectral imaging. Sci. World J. 7 (2007) 2046-2071
13. Anandasabapathy S. Endoscopic imaging: emerging optical techniques for the detection of colorectal neoplasia. Curr. Opin. Gastroenterol. 24 1 (2008) 64-69
14. van der Broek F.J., Fockens P., and Dekker E. New development in colonic imaging. Aliment Pharmacol Ther. Suppl. 2 (2007) 91-99
15. Hirata M., Tanaka S., Oka S., Kaneko I., Yoshida S., Yoshihara M., and Chayama K. Evaluation of microvessels in colorectal tumors by narrow band imaging magnification. Gastrointest. Endosc. 66 5 (2007) 945-952
16. Kelly K., Alencar H., Funovics M., Mahmood U., and Weissleder R. Detection of invasive colon cancer using a novel, targeted, library-derived fluorescent peptide. Cancer Res. 64 17 (2004) 6247-6251
17. K. Hiwatari, S. Sakuma, K. Iwata, Y. Masaoka, M. Kataoka, H. Tachikawa, Y. Shoji, S. Yamashita, Poly(N-vinylacetamide) chains enhance lectin-induced biorecognition through the reduction of nonspecific interactions with non-targets, Eur. J. Pharm. Biopharm. 70 (2) (2008) 453-461.
18. Boland C.R., and Roberts J.A. Quantitation of lectin binding sites in human colon mucins by use of peanut and wheat germ agglutinin. J. Histochem. Cytochem. 36 10 (1988) 1305-1307
19. Campbell B.J., Finnie I.A., Hounsell E.F., and Rhodes J.M. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen from colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin. J. Clin. Invest. 95 2 (1995) 571-576
20. Singh R., Campbell B.J., Yu L.-G., Fernig D.G., Milton J.D., Goodlad R.A., FitzGerald A.J., and Rhodes J.M. Cell surface-expressed Thomsen-Friedenreich antigen in colon cancer is predominantly carried on high molecular weight splice variants of CD44. Glycobiology 11 7 (2001) 587-592
21. Dabelsteen E. Cell surface carbohydrates as prognostic markers in human carcinomas. J. Pathol. 179 4 (1996) 358-369
22. Clark M.A., Hirst B.H., and Jepson M.A. Lectin-mediated mucosal delivery of drugs and microparticles. Adv. Drug Deliv. Rev. 43 2-3 (2000) 207-223
23. Bies C., Lehr C.-M., and Woodley J.F. Lectin-mediated drug targeting: history and applications. Adv. Drug Deliv. Rev. 56 4 (2004) 425-435
24. Gabor F., Bogner E., Weissenboeck A., and Wirth M. The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery. Adv. Drug Deliv. Rev. 56 4 (2004) 459-480
25. Rini J.M. Lectin structure. Annu. Rev. Biophys. Biomol. Struct. 24 (1995) 551-577
26. Wróblewski S., Kopečková P., Říhová B., and Kopeček J. Lectin-HPMA copolymer conjugates: potential oral drug carriers for targeting diseased tissues. Macromol. Chem. Phys. 199 11 (1998) 2601-2608
27. Wróblewski S., Berenson M., Kopečková P., and Kopeček J. Biorecognition of HPMA copolymer-lectin conjugates as an indicator of differentiation of cell-surface glycoproteins in development, maturation, and diseases of human and rodent gastrointestinal tissues. J. Biomed. Mater. Res. 51 3 (2000) 329-342
28. Wróblewski S., Berenson M., Kopečková P., and Kopeček J. Potential of lectin-N-(2-hydroxypropyl)methacrylamide copolymer-drug conjugates for the treatment of pre-cancerous conditions. J. Control. Release 74 1-3 (2001) 283-293
29. Sakuma S., Lu Z.-R., Kopečková P., and Kopeček J. Biorecognizable HPMA copolymer-drug conjugates for colon-specific delivery of 9-aminocamptothecin. J. Control. Release 75 3 (2001) 365-379
30. Sakuma S., Hayashi M., and Akashi M. Design of nanoparticles composed of graft copolymers for oral peptide delivery. Adv. Drug Deliv. Rev. 47 1 (2001) 21-37
31. Sakuma S., Sudo R., Suzuki N., Kikuchi H., Akashi M., and Hayashi M. Mucoadhesion of polystyrene nanoparticles having surface hydrophilic polymeric chains in the gastrointestinal tract. Int. J. Pharm. 177 2 (1999) 161-172
32. Sakuma S., Sudo R., Suzuki N., Kikuchi H., Akashi M., Ishida Y., and Hayashi M. Behavior of mucoadhesive nanoparticles having hydrophilic polymeric chains in the intestine. J. Control. Release 81 3 (2002) 281-290
33. Sakuma S., Suzuki N., Sudo R., Hiwatari K., Kishida A., and Akashi M. Optimized chemical structure of nanoparticles as carriers for oral delivery of salmon calcitonin. Int. J. Pharm. 239 1-2 (2002) 185-195
34. Akashi M., Niikawa T., Serizawa T., Hayakawa T., and Baba M. Capture of HIV-1 gp120 and virions by lectin-immobilized polystyrene nanospheres. Bioconjug. Chem. 9 1 (1998) 50-53
35. Akashi M., Wada M., Yanase S., and Miyauchi N. Polymer drugs and polymeric drugs, II. Synthesis of water dispersible microspheres having 5-fluorouracil and theophylline using a water soluble macromonomer. J. Polym. Sci. Part C: Polym. Lett. 27 (1989) 377-380
36. Chen M.-Q., Serizawa T., Li M., Wu C., and Akashi M. Thermosensitive behavior of poly(N-isopropylacrylamide) grafted polystyrene nanoparticles. Polym. J. 35 12 (2003) 901-910
37. Togo S., Shimada H., Kubota T., Moossa A., and Hoffman R.M. Host organ specifically determines cancer progression. Cancer Res. 55 3 (1995) 681-684
38. Yang M., Li L., Jiang P., Moossa A.R., Penman S., and Hoffman R.M. Dual-color fluorescence imaging distinguishes tumor cells from induced host angiogenic vessels and stromal cells. Proc. Natl. Acad. Sci. USA 100 24 (2003) 14259-14262
39. Amoh Y., Yang M., Li L., Reynoso J., Bouvet M., Moossa A.R., Katsuoka K., and Hoffman R.M. Nestin-linked green fluorescent protein transgenic nude mouse for imaging human tumor angiogenesis. Cancer Res. 65 12 (2005) 5352-5357
40. http://www.anticancer.com/.
41. Sharon N., and Lis H. Lectins as cell recognition molecules. Science 246 4927 (1989) 227-234
42. Corfield A.P., and Warren B.F. Mucus glycoproteins and their role in colorectal disease. J. Pathol. 180 1 (1996) 8-17
43. Gabor F., Stangl M., and Wirth M. Lectin-mediated bioadhesion: binding characteristics of plant lectins on the enterocyte-like cell lines Caco-2, HT-29 and HCT-8. J. Control. Release 55 2-3 (1998) 131-142
44. Hanisch F., Stadie T., Deutzmann F., and Peter-Katalinic J. MUC1 glycoforms in breast cancer-cell line T47D as a model for carcinoma-associated alterations of 0-glycosylation. Eur. J. Biochem. 236 1 (1996) 318-327
45. Samuel J., Noujaim A., MacLean G., Suresh M., and Longenecker B. Analysis of human tumor associated Thomsen-Friedenreich antigen. Cancer Res. 50 15 (1990) 4801-4808
46. Schneider F., Kemmner W., Haensch W., Franke G., Gretschel S., Karsten U., and Schlag P. Overexpression of sialyltransferase CMP-sialic acid: Galβ1,3GalNAc-R α6-sialyltransferase is related to poor patient survival in human colorectal carcinoma. Cancer Res. 61 11 (2001) 4605-4611
47. Zamai M., vandeVen M., Farao M., Gratton E., Ghiglieri A., Castelli M., Fontana E., d'Argy R., Fiorino A., Pesenti E., Suarato A., and Caiolfa V. Camptothecin poly[N-(2-hydroxypropyl)methacrylamide] copolymers in antitopoisomerase-I tumor therapy: intratumor release and antitumor efficacy. Mol. Cancer Ther. 2 1 (2003) 29-40
48. Akagi T., Higashi M., Kaneko T., Kida T., and Akashi M. Hydrolytic and enzymatic degradation of nanoparticles based on amphiphilic poly(γ-glutamic acid)-graft-l-phenylalanine copolymers. Biomacromolecules 7 (2006) 297-303
49. S. Sakuma, T. Sagawa, Y. Masaoka, M. Kataoka, S. Yamashita, Y. Shirasaka, I. Tamai, Y. Ikumi, T. Kida, M. Akashi, Stabilization of enzyme-susceptible glucoside bonds of phloridzin through conjugation with poly(γ-glutamic acid). J. Control. Release, in press.